Skip to main content
letter
. 2022 Jul 6;145(10):e95–e98. doi: 10.1093/brain/awac240

Table 1.

Phenotypic features and evolution of the PRDX3 patients

Patient 1 Patient 2
Demographics
Current age, years 18 51
Sex Female Male
Ethnicity Syrian (Kurdish) Turkish (nomads; Antalya)
Consanguinity Yes (first degree) Yes (third degree)
Family history Cousin, ataxia Brother: cerebellar ataxia with dysarthria (starting at age 30 years), liver cirrhosis (starting at age 39 years; no history of alcohol, negative for Wilson’s disease), death at age 52 years from liver cirrhosis
Mode of inheritance Autosomal recessive Autosomal recessive
Allele 1 c.43C>T (p.Arg15Ter) c.658C>T (Gln220Ter)
Allele 2 c.43C>T (p.Arg15Ter) c.658C>T (Gln220Ter)
Chromosome Chr10:119177147 Chr10:119169236
Transcript NM_006793.5 NM_006793.5
Delayed motor milestones Yes, first walking age 2 years Normal
Gait ataxia, age in years 2 35
Upper limb ataxia, age in years 3 36
Dysarthria None 35
Dysphagia, age in years 16 35
SARA (age in years) 7.5 (18) 12 (51)
Overall disease severity trajectory (by history) Improving (slowly) Worsening (slowly)
Age at last exam, years 18 51
Oculomotor signs No saccadic pursuit, hypometric saccades Saccadic pursuit, hypermetric saccades
Cerebellar dysarthria No Yes
Hypokinetic features No Hypomimia
Hyperkinetic features No Spontaneous startling reactions
Pyramidal signs No No
Muscle weakness No No
Sensory impairment No No
Cognitive impairment No No
MRI Cerebellar atrophy, T2 hyperintense signals cerebellum and brainstem Cerebellar atrophy, T2 hyperintense signals cerebellum and brainstem

No = absent; SARA = Scale for the Assessment and Rating of Ataxia; Yes = present.